報價延遲最少15分鐘:2025/01/21 08:40 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.77 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.69/-0.20
|
|
企業價值
678.36M
|
| 資產負債 |
|
每股賬面淨值
1.31
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
97.95M
|
|
每股收益
0.28
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/01/21 08:40 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas. |